Drugs /
bms-986288
Back to Drugs List
Overview
Clinical Trials
Bms-986288 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating bms-986288, 1 is phase 1/phase 2 (1 open).
Malignant solid tumor is the most common disease being investigated in bms-986288 clinical trials [2].
Drug Details
Drug Target(s) [2]:
CTLA4
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.
